Journal of Clinical Medicine (Sep 2022)

Brugada Syndrome Associated with Different Heterozygous <i>SCN5A</i> Variants in Two Unrelated Families

  • Nadine Molitor,
  • Argelia Medeiros-Domingo,
  • Siv Fokstuen,
  • Frank Ruschitzka,
  • Firat Duru,
  • Ardan Saguner

DOI
https://doi.org/10.3390/jcm11195625
Journal volume & issue
Vol. 11, no. 19
p. 5625

Abstract

Read online

The cardiac sodium channel (Nav1.5) controls cardiac excitability by triggering the action potential of cardiac myocytes and controlling electric impulse transmission. However, it has also been associated with arrhythmogenic cardiomyopathies. Accordingly, genetic variants in SCN5A that result in loss of function of Nav1.5 are associated with inherited arrhythmia syndromes, which are caused by reduced cardiac excitability, particularly Brugada syndrome (BrS) as well as arrhythmogenic right ventricular cardiomyopathy (ARVC). We report a novel pathogenic SCNA5 variant being associated with BrS overlapping with ARVC, as well as disease progression with a previously reported SCN5A variant being associated with a phenotype of BrS and conduction system disorder in two unrelated families.

Keywords